2020 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA)

Event Human COVID-19 Paediatrics

Date: Monday, 28 September 2020, All day
Location: Online

European Medicines Agency, Amsterdam, the Netherlands

Event summary

In 2020, Enpr-EMA held a meeting with the Coordinating Group and networks only instead of its regular annual workshop, considering the Agency’s business continuity plan related to COVID-19.

The European Commission provided feedback on the evaluation of the Paediatric and Orphan Regulations, as well as on the EU Pharmaceutical Strategy. Moreover, the meeting focused on the impact of COVID-19 in the paediatric population and facilitated a dialogue on overcoming the challenges caused by the pandemic on clinical trials in children, and learnings for the future.

Documents

Agenda - 2020 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA)

Reference Number: EMA/440708/2020

English (EN) (249.48 KB - PDF)

First published: 16/12/2020

Report from the 2020 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA)

Reference Number: EMA/518319/2020

English (EN) (365.49 KB - PDF)

First published: 16/12/2020

Presentation - c4c Business Continuity Planning (M. Turner)

English (EN) (3.49 MB - PDF)

First published: 15/12/2020

Presentation - c4c update for Enpr-EMA (M. Turner)

English (EN) (1.83 MB - PDF)

First published: 15/12/2020

Presentation - Providing high-quality care remotely to patients with Rare Bone Diseases during COVID-19 pandemic (L. Sangiorgi)

English (EN) (1.55 MB - PDF)

First published: 15/12/2020

Presentation - COVID-19 and Clinical Research in Canada (T. Lacaze)

English (EN) (296.41 KB - PDF)

First published: 15/12/2020

Presentation - COVID-19 impact on paediatric clinical trials, and how to overcome the challenges. Can some new approaches be taken forward for future paediatric trials? Industry perspective (M. Dehlinger-Kremer, C. Ollivier)

English (EN) (2.33 MB - PDF)

First published: 15/12/2020

Presentation - ERICA - ERN rare disease research coordination & support action (L. Sangiorgi)

English (EN) (504.26 KB - PDF)

First published: 15/12/2020

Presentation - European Paediatric Translational Research Infrastructure (EPTRI) (D. Bonifazi)

English (EN) (3.38 MB - PDF)

First published: 15/12/2020

Presentation - Evaluation of the legislation on medicines for children and rare diseases (F. D’Atri)

English (EN) (291.28 KB - PDF)

First published: 15/12/2020

Presentation - Multi-Regional Clinical Trials (MRCT) Centerand its initiative on promoting global clinical research in children (D. Karres)

English (EN) (259.96 KB - PDF)

First published: 15/12/2020

Presentation - Multisystem inflammatory syndrome in children and adolescents (temporally related to COVID-19) (L. Fregonese)

English (EN) (761.92 KB - PDF)

First published: 15/12/2020

Presentation - Pharmaceutical strategy for Europe (A. Rodiadis)

English (EN) (858.52 KB - PDF)

First published: 15/12/2020

Presentation - Preparedness for paediatric COVID vaccine trials (L. Fregonese)

English (EN) (780.62 KB - PDF)

First published: 15/12/2020

Presentation - Enpr-EMA Annual Report 2019-2020 (P. Lepola)

English (EN) (282.76 KB - PDF)

First published: 15/12/2020

Presentation - WG on clinical practice evidence in the labelling (S. de Wildt)

English (EN) (523.6 KB - PDF)

First published: 15/12/2020

Presentation - Enpr-EMA Nurse - Coordinator Working Group (V.O’Mahony, P. Dicks)

English (EN) (214.75 KB - PDF)

First published: 15/12/2020